Inhibition of RAN attenuates influenza a virus replication and nucleoprotein nuclear export.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE
    • Publication Information:
      Publication: 2019- : [Philadelphia, PA] : Taylor & Francis
      Original Publication: New York : NPG, 2012-2018.
    • Subject Terms:
    • Abstract:
      Nuclear export of the viral ribonucleoprotein (vRNP) is a critical step in the influenza A virus (IAV) life cycle and may be an effective target for the development of anti-IAV drugs. The host factor ras-related nuclear protein (RAN) is known to participate in the life cycle of several viruses, but its role in influenza virus replication remains unknown. In the present study, we aimed to determine the function of RAN in influenza virus replication using different cell lines and subtype strains. We found that RAN is essential for the nuclear export of vRNP, as it enhances the binding affinity of XPO1 toward the viral nuclear export protein NS2. Depletion of RAN constrained the vRNP complex in the nucleus and attenuated the replication of various subtypes of influenza virus. Using in silico compound screening, we identified that bepotastine could dissociate the RAN-XPO1-vRNP trimeric complex and exhibit potent antiviral activity against influenza virus both in vitro and in vivo . This study demonstrates the important role of RAN in IAV replication and suggests its potential use as an antiviral target.
    • References:
      J Biol Chem. 2002 May 17;277(20):17385-8. (PMID: 11932251)
      Virology. 2013 Aug 15;443(1):177-85. (PMID: 23711384)
      ACS Med Chem Lett. 2023 May 30;14(6):860-866. (PMID: 37284689)
      PLoS One. 2015 Apr 24;10(4):e0124651. (PMID: 25909503)
      J Clin Virol. 2011 Oct;52(2):70-8. (PMID: 21684202)
      Nat Rev Microbiol. 2016 Aug;14(8):479-93. (PMID: 27396566)
      Lancet Infect Dis. 2012 Mar;12(3):240-8. (PMID: 22186145)
      Cell Rep. 2019 May 7;27(6):1875-1885.e5. (PMID: 31067470)
      Nucleic Acids Res. 1999 Nov 1;27(21):4128-34. (PMID: 10518602)
      Exp Mol Med. 2021 May;53(5):737-749. (PMID: 33953324)
      Clin Infect Dis. 2019 May 17;68(11):1839-1846. (PMID: 30239636)
      J Virol. 2015 Nov 18;90(3):1424-38. (PMID: 26581983)
      Virology. 2011 Aug 15;417(1):37-49. (PMID: 21620431)
      J Biol Chem. 2014 Jul 18;289(29):20067-77. (PMID: 24891509)
      Drugs. 2011 Aug 20;71(12):1591-622. (PMID: 21861544)
      EMBO J. 1997 Mar 17;16(6):1248-57. (PMID: 9135141)
      Mol Cell Biol. 1990 Apr;10(4):1793-8. (PMID: 2108320)
      Antiviral Res. 2023 Jul;215:105635. (PMID: 37192683)
      Traffic. 2005 Mar;6(3):187-98. (PMID: 15702987)
      Cell Mol Life Sci. 2022 Jan 10;79(1):65. (PMID: 35013790)
      Virus Res. 2001 Sep;77(1):31-42. (PMID: 11451485)
      Mol Cell. 2004 Dec 3;16(5):761-75. (PMID: 15574331)
      PLoS Pathog. 2023 Jul 17;19(7):e1011506. (PMID: 37459366)
      J Ethnopharmacol. 2011 Jun 1;135(3):719-24. (PMID: 21501677)
      Biotechnol J. 2015 May;10(5):690-701. (PMID: 25728134)
      J Cell Sci. 1996 Oct;109 ( Pt 10):2423-7. (PMID: 8923203)
      Eur J Pharmacol. 2006 Oct 10;547(1-3):59-64. (PMID: 16914135)
      EMBO J. 2003 Sep 15;22(18):4646-55. (PMID: 12970177)
      Curr Med Res Opin. 2010 Oct;26(10):2329-38. (PMID: 20735291)
      Nat Rev Clin Oncol. 2021 Mar;18(3):152-169. (PMID: 33173198)
      Cell Host Microbe. 2010 Jun 25;7(6):440-51. (PMID: 20542248)
      J Virol. 2014 Sep 1;88(17):10228-43. (PMID: 24965445)
      Cell Mol Life Sci. 2015 Mar;72(5):971-82. (PMID: 25213355)
      Int Immunopharmacol. 2023 Jun;119:110226. (PMID: 37159964)
      Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595. (PMID: 32571934)
      J Virol. 2013 Jan;87(2):767-78. (PMID: 23115280)
      PLoS Pathog. 2011 Sep;7(9):e1002187. (PMID: 21909257)
      Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16557-16566. (PMID: 32601201)
      Vet Microbiol. 2023 Sep;284:109827. (PMID: 37542928)
      Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1201-1208. (PMID: 32056049)
      J Asthma Allergy. 2018 Mar 23;11:29-39. (PMID: 29615844)
      EMBO J. 1996 Oct 15;15(20):5584-94. (PMID: 8896452)
      J Mol Biol. 2016 May 22;428(10 Pt A):2025-39. (PMID: 26519791)
      Sci Adv. 2020 Jun 19;6(25):eaaz5764. (PMID: 32596447)
      Sci Rep. 2016 Sep 20;6:33608. (PMID: 27646999)
      Nature. 2020 Jun;582(7811):289-293. (PMID: 32272481)
      Sci Rep. 2021 Jan 13;11(1):979. (PMID: 33441577)
      Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L270-86. (PMID: 25361566)
      Curr Opin Virol. 2015 Oct;14:71-8. (PMID: 26364134)
      Curr Opin Cell Biol. 1998 Jun;10(3):400-8. (PMID: 9640542)
      Aging (Albany NY). 2020 Apr 1;12(7):5751-5763. (PMID: 32235005)
      World J Virol. 2016 May 12;5(2):85-6. (PMID: 27175354)
      Nat Cell Biol. 2002 Jul;4(7):E177-84. (PMID: 12105431)
      Emerg Microbes Infect. 2022 Dec;11(1):1371-1389. (PMID: 35476817)
      Science. 2023 Feb 10;379(6632):586-591. (PMID: 36758070)
      Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1303-8. (PMID: 23297231)
      Science. 2009 May 22;324(5930):1087-91. (PMID: 19389996)
      Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):960-5. (PMID: 23277578)
      mBio. 2024 May 8;15(5):e0017524. (PMID: 38551343)
    • Contributed Indexing:
      Keywords: Influenza A virus; RAN; bepotastine; nuclear export; viral ribonucleoprotein
    • Accession Number:
      EC 3.6.5.2 (ran GTP-Binding Protein)
      0 (Antiviral Agents)
      0 (Exportin 1 Protein)
      0 (Karyopherins)
      0 (Receptors, Cytoplasmic and Nuclear)
      0 (RAN protein, human)
      0 (Viral Nonstructural Proteins)
      0 (Piperidines)
      0 (NS2 protein, influenza virus A)
      0 (Nucleoproteins)
      0 (Ribonucleoproteins)
    • Publication Date:
      Date Created: 20240801 Date Completed: 20240812 Latest Revision: 20240923
    • Publication Date:
      20240923
    • Accession Number:
      PMC11321118
    • Accession Number:
      10.1080/22221751.2024.2387910
    • Accession Number:
      39087696